CStone Pharmaceuticals (2616.HK) HKSE
Currency In HKD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 6.57B |
| Enterprise Value | 6.17B |
| P/E Ratio | -15.87 |
| PEG Ratio | 0.39 |
| Price/Sales Ratio | 16.18 |
| Price/Book Ratio | 5.05 |
| Enterprise/Revenue | 13.72 |
| Enterprise/EBITDA | -17.72 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | -0.98 |
| Operating Margin | -0.92 |
AD
Management Effectiveness
| Return On Assets | -0.2 |
| Return On Equity | -0.44 |
Income Statement
| Revenue | 269.58M |
| Revenue/Share | 0.28 |
| Gross Profit | 51.25M |
| EBITDA | -371.84M |
| Net Income | -437M |
| Diluted EPS | -0.31 |
Balance Sheet
| Total Cash | 1.56B |
| Total Cash/Share | 1.03 |
| Total Debt | 357.17M |
| Total Debt/Equity | 0.28 |
| Current Ratio | 3.58 |
| Book Value Per Share | 0.85 |
Price History
| 52-Week Change | -29.41 |
| 52-Week High | 10.41 |
| 52-Week Low | 4.01 |
| Moving Average 50 Days | 5.61 |
| Moving Average 200 Days | 6.29 |
Statistics
| Average Volume | 9.03M |
| Shares Outstanding | 1.59B |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
